Abpro Corporation
NASDAQ: ABP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jin Wook Suk
- Employees
- 6
- Headquarters
- Woburn, United States
- IPO year
- 2022
- Market cap
- $1.1M
- Website
- https://abpro.com
Loading ABP…
Loading profile data…Frequently asked questions about ABP
What does Abpro Corporation (ABP) do?
Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their pr...
Where does ABP trade?
Abpro Corporation (ABP) trades on the NASDAQ Global Market.
What sector is ABP in?
Abpro Corporation (ABP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Abpro Corporation?
Jin Wook Suk is the chief executive officer of Abpro Corporation (ABP).
Where is Abpro Corporation headquartered?
Abpro Corporation is headquartered in United States.
Does ABP pay a dividend?
Abpro Corporation (ABP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ABP go public?
Abpro Corporation (ABP) completed its initial public offering in 2022.